Lord, Abbett & Co. LLC Aclaris Therapeutics, Inc. Transaction History

Lord, Abbett & Co. LLC

  • $30.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 07, 2024
BUY
$6.56 - $10.95 $364,749 - $608,841
55,602 Added 13.96%
453,954 $3.11 Million
Q3 2023

Nov 13, 2023
BUY
$6.56 - $10.95 $364,749 - $608,841
55,602 Added 13.96%
453,954 $3.11 Million
Q2 2023

Oct 07, 2024
BUY
$7.89 - $10.64 $3.14 Million - $4.24 Million
398,352 New
398,352 $4.13 Million
Q2 2023

Aug 14, 2023
BUY
$7.89 - $10.64 $3.14 Million - $4.24 Million
398,352 New
398,352 $4.13 Million

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $253M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email